Preeclampsia / Eclampsia / HELLP Syndrome

Snapshot

  • A 36-year-old woman at 34 weeks gestation presents to the emergency room for abdominal pain and headaches. She reports noticing these symptoms last night but attributed it to eating some take-out last night. On physical exam, she has tenderness to palpation in the epigastrium. Her blood pressure is 166/115 mmHg. She begins having tonic-clonic seizures. She is immediately prepped for delivery via cesarean section and started on anti-seizure medications. (Eclampsia)

Introduction

  • Overview
    • hypertension during pregnancy can be chronic hypertension, gestational hypertension, preeclamspia, or eclampsia
    • some consider HELLP syndrome to be a form of preeclampsia/eclampsia although this is controversial 
  • Diagnosis of preeclampsia
    • hypertension (> 140/90 mmHg on 2 separate occasions, or 160/110 mmHg) and proteinuria
    • can also be diagnosed without proteinuria if one of the following signs of severe preeclampsia 
      • blood pressure >160/110
      • hepatic dysfunction
      • renal insufficiency
      • visual/cerebral disturbances
      • pulmonary edema
      • thrombocytopenia
Spectrum of Hypertensive Disorders in Pregnancy
Chronic HypertensionGestational HypertensionPreeclampsiaEclampsia HELLP Syndrome  
History of hypertension (> 140/90 mmgHg) before pregnancy or before 20 weeks of gestationHypertension persists after deliveryHypertension after 20 weeks of gestationHypertension returns to baseline by 6 weeks post-partumCommon in multiple gestationsHypertension (> 140/90 mmHg on 2 separate occasions, or >160/110 mmHg) plus proteinuriaPreeclampsia plus seizuresHemolysisElevated Liver enzymesLow Platelets
  • Epidemiology
    • incidence
      • preeclampsia/eclampsia
        • 2-6%
      • HELLP syndrome
        • 0.1-0.6%
    • risk factors
      • preeclampsia/eclampsia
        • nulliparity  
        • multiple gestations
        • hyatidiform mole
        • diabetes
        • chronic hypertension
        • chronic renal disease
      • HELLP syndrome
        • maternal age > 34 years
        • multiparity
        • Caucasian/European descent
  • Pathogenesis
    • mechanism
      • preeclampsia/eclampsia
        • impaired vasodilation of spiral arteries cause placental ischemia
        • this results in increased vascular tone, increased vasoconstriction, and decreased vasodilation
        • other factors considered to contribute include maternal immunologic intolerance, inflammatory changes, and abnormal placental implantation
        • vasospasm of the renal arteries can lead to acute renal failure 
      • HELLP syndrome
        • thought to be due to endothelial activation, consumption of platelets, microangiopathic hemolysis, and microvascular injury
        • complement dysfunction may also play a role
  • Prognosis
    • preeclampsia/eclampsia
      • maternal mortality 14%
    • HELLP syndrome
      • maternal mortality 1-3%
  • most resolve after delivery

Presentation

  • Symptoms 
    • there is often overlap between preeclampsia/eclampsia and HELLP syndrome
    • common symptoms
      • headache
      • epigastric or right upper quadrant pain
      • visual changes
      • pulmonary edema
      • oliguria
      • water retention
  • Physical exam
    • inspection
      • hypertension > 140/90 mmHg
      • tonic-clonic seizures
      • hyperreflexia
      • periorbital and extremity edema 
      • altered mental status
  • jaundice

Studies

  • Serum labs
    • proteinuria
      • 1-2+ on dipstick
      • > 300 mg on 24-hour urine
      • protein/creatinine ratio > 0.3 
        • best confirmatory test is a spot urine protein to creatinine ratio
    • thrombocytopenia
    • hemoconcentration
    • elevated liver enzymes in HELLP syndrome
    • hemolysis in HELLP syndrome
      • elevated lactate dehydrogenase
      • elevated bilirubin
      • hemolysis on peripheral smear
  • schistocytes, helmet cells, or burr cells

Differential

  • Acute fatty liver of pregnancy
    • key distinguishing factor
  • characterized primarily with fulminant liver failure

Treatment

  • Medical
    • antihypertensive medication
      • indications
        • preeclampsia/eclampsia and HELLP syndrome
        • blood pressure > 160/100 mmHg
          • risk of decreased utero-placental blood flow
      • drugs
        • labetalol
        • methyldopa
        • hydralazine
    • intravenous steroids
      • indications
        • thrombocytopenia
        • HELLP syndrome
    • intravenous magnesium sulfate or diazepam 
      • indications
        • seizure prophylaxis and treatment
        • preeclampsia/eclampsia and HELLP syndrome
      • magnesium toxicity can occur 
        • hyporeflexia presents before bradypnea
        • treatment
          • calcium gluconate
  • Surgical
    • delivery
      • indications
        • the only definitive treatment
        • if mild preeclampsia or stable with HELLP syndrome, can monitor for progression
  • if severe preeclampsia, eclampsia, or unstable, deliver immediately
  •  

Complications

  • Complications
    • preeclampsia/eclampsia
      • maternal cerebral hemorrhage
      • disseminated intravascular coagulopathy
      • acute respiratory distress syndrome
      • abruptio placentae
      • recurrence of preeclampsia
    • HELLP syndrome
      • maternal complications
        • cerebral hemorrhage
        • disseminated intravascular coagulopathy
        • acute renal failure
        • hepatic rupture
        • risk of recurrence in subsequent pregnancies
        • increased risk of preeclampsia, preterm delivery, and placental abruption
      • neonatal complications
        • prematurity
        • intrauterine growth retardation
        • fetal demise
      • other complications
        • increased risk of cardiovascular disease